DNER and leukemia: In a recent study by Kim et al., it was shown that BET inhibition by GS-5829 in combination with Ibrutinib (BTK inhibitor) or Entospletinib synergistically increased anti-leukemia activity and induced apoptosis in primary co-cultured CLL cells [26].